Q1 2025 EPS Estimates for inTEST Co. Lowered by Northland Capmk (NYSE:INTT)

inTEST Co. (NYSE:INTT) – Northland Capmk dropped their Q1 2025 earnings estimates for shares of inTEST in a report released on Tuesday, May 7th. Northland Capmk analyst E. Jackson now anticipates that the company will post earnings of $0.19 per share for the quarter, down from their previous estimate of $0.21. The consensus estimate for inTEST’s current full-year earnings is $1.04 per share. Northland Capmk also issued estimates for inTEST’s Q2 2025 earnings at $0.20 EPS, Q3 2025 earnings at $0.22 EPS, Q4 2025 earnings at $0.29 EPS, FY2025 earnings at $0.89 EPS, FY2026 earnings at $1.03 EPS, FY2027 earnings at $1.24 EPS and FY2028 earnings at $1.47 EPS.

inTEST (NYSE:INTT) last announced its quarterly earnings data on Monday, May 6th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. inTEST had a return on equity of 13.46% and a net margin of 8.02%. The business had revenue of $29.82 million during the quarter, compared to the consensus estimate of $29.10 million.

A number of other research firms also recently issued reports on INTT. StockNews.com downgraded shares of inTEST from a “buy” rating to a “hold” rating in a report on Saturday, April 6th. Lake Street Capital dropped their price objective on inTEST from $19.00 to $16.00 and set a “buy” rating for the company in a report on Tuesday.

inTEST Stock Down 5.1 %

INTT opened at $10.08 on Wednesday. inTEST has a 12 month low of $9.71 and a 12 month high of $27.17. The business has a 50-day moving average of $11.64 and a two-hundred day moving average of $12.21. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.53 and a quick ratio of 2.70. The stock has a market capitalization of $125.88 million, a price-to-earnings ratio of 15.51 and a beta of 2.01.

Insider Transactions at inTEST

In related news, CEO Richard N. Jr. Grant sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $12.80, for a total value of $256,000.00. Following the transaction, the chief executive officer now owns 215,217 shares in the company, valued at $2,754,777.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO Richard N. Jr. Grant sold 21,500 shares of the stock in a transaction dated Thursday, April 11th. The stock was sold at an average price of $12.03, for a total value of $258,645.00. Following the completion of the sale, the chief executive officer now owns 171,717 shares in the company, valued at $2,065,755.51. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Richard N. Jr. Grant sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, April 9th. The shares were sold at an average price of $12.80, for a total value of $256,000.00. Following the sale, the chief executive officer now owns 215,217 shares in the company, valued at $2,754,777.60. The disclosure for this sale can be found here. Company insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On inTEST

Institutional investors and hedge funds have recently bought and sold shares of the stock. Stansberry Asset Management LLC lifted its position in shares of inTEST by 145.8% during the third quarter. Stansberry Asset Management LLC now owns 113,911 shares of the company’s stock worth $1,728,000 after purchasing an additional 67,561 shares in the last quarter. Great Valley Advisor Group Inc. acquired a new position in inTEST in the 3rd quarter worth $167,000. First Eagle Investment Management LLC boosted its position in inTEST by 49.0% in the 3rd quarter. First Eagle Investment Management LLC now owns 359,948 shares of the company’s stock valued at $5,460,000 after buying an additional 118,449 shares during the last quarter. WINTON GROUP Ltd acquired a new stake in shares of inTEST during the third quarter valued at about $309,000. Finally, Barclays PLC increased its position in shares of inTEST by 161.9% during the third quarter. Barclays PLC now owns 7,521 shares of the company’s stock worth $114,000 after acquiring an additional 4,649 shares during the last quarter. Hedge funds and other institutional investors own 63.18% of the company’s stock.

About inTEST

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.